Cargando…

Estimating asymptomatic SARS-CoV-2 infections in a geographic area of low disease incidence

BACKGROUND: The SARS-CoV-2 infection has emerged as a rapidly spreading infection. Today it is relatively easy to isolate Covid-19 symptomatic cases, while remains problematic to control the disease spread by infected but symptom-free individuals. The control of this possible path of contagion requi...

Descripción completa

Detalles Bibliográficos
Autores principales: Caturano, Valeria, Manti, Barbara, Carbone, Fortunata, Lasorsa, Vito Alessandro, Colicchio, Roberta, Capasso, Mario, Leonardi, Antonio, Matarese, Giuseppe, Russo, Tommaso, Salvatore, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046491/
https://www.ncbi.nlm.nih.gov/pubmed/33853532
http://dx.doi.org/10.1186/s12879-021-06054-2
_version_ 1783678861791199232
author Caturano, Valeria
Manti, Barbara
Carbone, Fortunata
Lasorsa, Vito Alessandro
Colicchio, Roberta
Capasso, Mario
Leonardi, Antonio
Matarese, Giuseppe
Russo, Tommaso
Salvatore, Paola
author_facet Caturano, Valeria
Manti, Barbara
Carbone, Fortunata
Lasorsa, Vito Alessandro
Colicchio, Roberta
Capasso, Mario
Leonardi, Antonio
Matarese, Giuseppe
Russo, Tommaso
Salvatore, Paola
author_sort Caturano, Valeria
collection PubMed
description BACKGROUND: The SARS-CoV-2 infection has emerged as a rapidly spreading infection. Today it is relatively easy to isolate Covid-19 symptomatic cases, while remains problematic to control the disease spread by infected but symptom-free individuals. The control of this possible path of contagion requires drastic measures of social distancing, which imply the suspension of most activities and generate economic and social issues. This study is aimed at estimating the percentage of asymptomatic SARS-CoV-2 infection in a geographic area with relatively low incidence of Covid-19. METHODS: Blood serum samples from 388 healthy volunteers were analyzed for the presence of anti-SARS-CoV-2 IgG by using an ELISA assay based on recombinant viral nucleocapsid protein. RESULTS: We found that 7 out of 388 healthy volunteers, who declared no symptoms of Covid-19, like fever, cough, fatigue etc., in the preceding 5 months, have bona fide serum anti-SARS-CoV-2 IgG, that is 1.8% of the asymptomatic population (95% confidence interval: 0.69–2.91%). CONCLUSIONS: The estimated range of asymptomatic individuals with anti-SARS-CoV-2 IgG should be between 26,565 and 112, 350. In the same geographic area, there are 4665 symptomatic diagnosed cases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06054-2.
format Online
Article
Text
id pubmed-8046491
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80464912021-04-15 Estimating asymptomatic SARS-CoV-2 infections in a geographic area of low disease incidence Caturano, Valeria Manti, Barbara Carbone, Fortunata Lasorsa, Vito Alessandro Colicchio, Roberta Capasso, Mario Leonardi, Antonio Matarese, Giuseppe Russo, Tommaso Salvatore, Paola BMC Infect Dis Research BACKGROUND: The SARS-CoV-2 infection has emerged as a rapidly spreading infection. Today it is relatively easy to isolate Covid-19 symptomatic cases, while remains problematic to control the disease spread by infected but symptom-free individuals. The control of this possible path of contagion requires drastic measures of social distancing, which imply the suspension of most activities and generate economic and social issues. This study is aimed at estimating the percentage of asymptomatic SARS-CoV-2 infection in a geographic area with relatively low incidence of Covid-19. METHODS: Blood serum samples from 388 healthy volunteers were analyzed for the presence of anti-SARS-CoV-2 IgG by using an ELISA assay based on recombinant viral nucleocapsid protein. RESULTS: We found that 7 out of 388 healthy volunteers, who declared no symptoms of Covid-19, like fever, cough, fatigue etc., in the preceding 5 months, have bona fide serum anti-SARS-CoV-2 IgG, that is 1.8% of the asymptomatic population (95% confidence interval: 0.69–2.91%). CONCLUSIONS: The estimated range of asymptomatic individuals with anti-SARS-CoV-2 IgG should be between 26,565 and 112, 350. In the same geographic area, there are 4665 symptomatic diagnosed cases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-021-06054-2. BioMed Central 2021-04-15 /pmc/articles/PMC8046491/ /pubmed/33853532 http://dx.doi.org/10.1186/s12879-021-06054-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Caturano, Valeria
Manti, Barbara
Carbone, Fortunata
Lasorsa, Vito Alessandro
Colicchio, Roberta
Capasso, Mario
Leonardi, Antonio
Matarese, Giuseppe
Russo, Tommaso
Salvatore, Paola
Estimating asymptomatic SARS-CoV-2 infections in a geographic area of low disease incidence
title Estimating asymptomatic SARS-CoV-2 infections in a geographic area of low disease incidence
title_full Estimating asymptomatic SARS-CoV-2 infections in a geographic area of low disease incidence
title_fullStr Estimating asymptomatic SARS-CoV-2 infections in a geographic area of low disease incidence
title_full_unstemmed Estimating asymptomatic SARS-CoV-2 infections in a geographic area of low disease incidence
title_short Estimating asymptomatic SARS-CoV-2 infections in a geographic area of low disease incidence
title_sort estimating asymptomatic sars-cov-2 infections in a geographic area of low disease incidence
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046491/
https://www.ncbi.nlm.nih.gov/pubmed/33853532
http://dx.doi.org/10.1186/s12879-021-06054-2
work_keys_str_mv AT caturanovaleria estimatingasymptomaticsarscov2infectionsinageographicareaoflowdiseaseincidence
AT mantibarbara estimatingasymptomaticsarscov2infectionsinageographicareaoflowdiseaseincidence
AT carbonefortunata estimatingasymptomaticsarscov2infectionsinageographicareaoflowdiseaseincidence
AT lasorsavitoalessandro estimatingasymptomaticsarscov2infectionsinageographicareaoflowdiseaseincidence
AT colicchioroberta estimatingasymptomaticsarscov2infectionsinageographicareaoflowdiseaseincidence
AT capassomario estimatingasymptomaticsarscov2infectionsinageographicareaoflowdiseaseincidence
AT leonardiantonio estimatingasymptomaticsarscov2infectionsinageographicareaoflowdiseaseincidence
AT mataresegiuseppe estimatingasymptomaticsarscov2infectionsinageographicareaoflowdiseaseincidence
AT russotommaso estimatingasymptomaticsarscov2infectionsinageographicareaoflowdiseaseincidence
AT salvatorepaola estimatingasymptomaticsarscov2infectionsinageographicareaoflowdiseaseincidence